Es gab 50 kürzliche Insider-Transaktionen für Neoleukin Therapeutics, Inc. (NLTX), darunter 31 Käufe und 15 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $5.24M und die gesamten Insider-Verkäufe auf $330.71K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Baffi Robert, Palekar Rohan, Noonberg Sarah B.. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — NLTX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-01-16 |
Baffi Robert |
Director |
RSU-Zuteilung |
15,400 |
$32.30 |
$497.42K |
15,400 |
| 2024-01-16 |
Palekar Rohan |
Director |
RSU-Zuteilung |
15,400 |
$32.30 |
$497.42K |
15,400 |
| 2024-01-16 |
Noonberg Sarah B. |
Director |
RSU-Zuteilung |
15,400 |
$32.30 |
$497.42K |
15,400 |
| 2024-01-16 |
Freedland Cory S. |
Director |
RSU-Zuteilung |
15,400 |
$32.30 |
$497.42K |
15,400 |
| 2024-01-16 |
Jordan Julie |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-01-16 |
Jordan Julie |
Chief Medical Officer |
RSU-Zuteilung |
75,000 |
$32.30 |
$2.42M |
75,000 |
| 2024-01-16 |
Woods Robert Keith |
Director |
RSU-Zuteilung |
15,400 |
$32.30 |
$497.42K |
15,400 |
| 2023-12-18 |
Baker Bros. Advisors Lp |
Director |
RSU-Zuteilung |
78,325 |
- |
- |
78,325 |
| 2023-12-18 |
Baffi Robert |
Director |
Veräußerung |
2,570 |
$18.39 |
$47.26K |
- |
| 2023-12-18 |
Cvijic Christine Mikail |
President and CFO |
Veräußerung |
29,453 |
$5.82 |
$171.42K |
- |
| 2023-12-18 |
Mcminn Rachel |
Chief Executive Officer |
Veräußerung |
1,718 |
$6.40 |
$11K |
- |
| 2023-12-18 |
Freedland Cory S. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-12-18 |
Cobb Stuart |
Chief Scientific Officer |
Veräußerung |
13,514 |
$5.82 |
$78.65K |
- |
| 2023-12-18 |
Woods Robert Keith |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-10-05 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Optionsausübung (ITM) |
57,049 |
$0.00 |
$0.29 |
155,874 |
| 2023-08-17 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Informierter Kauf |
7,676 |
$0.69 |
$5.31K |
489,092 |
| 2023-08-16 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Informierter Kauf |
17,124 |
$0.68 |
$11.65K |
481,050 |
| 2023-08-15 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Informierter Kauf |
143,519 |
$0.63 |
$90.53K |
463,568 |
| 2023-08-11 |
Smith Sean Michael |
Interim CFO, Prin Acct Off |
Informierter Verkauf |
1,323 |
$0.62 |
$818.14 |
21,637 |
| 2023-08-10 |
Smith Sean Michael |
Interim CFO, Prin Acct Off |
Optionsausübung (Verkauf) |
5,000 |
- |
- |
- |
| 2023-06-08 |
Simpson Todd E |
Director |
RSU-Zuteilung |
25,000 |
$0.79 |
$19.75K |
25,000 |
| 2023-06-08 |
Palekar Rohan |
Director |
RSU-Zuteilung |
25,000 |
$0.79 |
$19.75K |
25,000 |
| 2023-06-08 |
Babler Martin |
Director |
RSU-Zuteilung |
25,000 |
$0.79 |
$19.75K |
25,000 |
| 2023-06-08 |
Noonberg Sarah B. |
Director |
RSU-Zuteilung |
25,000 |
$0.79 |
$19.75K |
25,000 |
| 2023-06-08 |
Lavelle Erin |
Director |
RSU-Zuteilung |
25,000 |
$0.79 |
$19.75K |
25,000 |
| 2023-06-08 |
Baker Bros. Advisors Lp |
Director |
RSU-Zuteilung |
25,000 |
$0.79 |
$19.75K |
25,000 |
| 2023-04-03 |
Patel Priti |
Officer |
Informierter Verkauf |
3,769 |
$0.69 |
$2.61K |
37,313 |
| 2023-03-31 |
Patel Priti |
Officer |
Optionsausübung (Verkauf) |
10,000 |
- |
- |
- |
| 2023-02-02 |
Patel Priti |
Chief Medical Officer |
Informierter Verkauf |
14,380 |
$0.60 |
$8.59K |
31,082 |
| 2023-02-02 |
Smith Sean Michael |
Principal Accounting Officer |
Informierter Verkauf |
3,316 |
$0.60 |
$1.98K |
15,960 |
| 2023-02-01 |
Patel Priti |
Chief Medical Officer |
Optionsausübung (Verkauf) |
35,000 |
- |
- |
35,000 |
| 2023-02-01 |
Smith Sean Michael |
Principal Accounting Officer |
Optionsausübung (Verkauf) |
12,500 |
- |
- |
12,500 |
| 2022-08-10 |
Smith Sean Michael |
Principal Accounting Officer |
Informierter Verkauf |
1,655 |
$0.99 |
$1.64K |
6,776 |
| 2022-08-02 |
Drachman Jonathan G |
President and CEO |
RSU-Zuteilung |
350,000 |
- |
- |
350,000 |
| 2022-08-02 |
Walkey Carl |
Senior Vice President |
RSU-Zuteilung |
150,000 |
- |
- |
150,000 |
| 2022-08-02 |
Patel Priti |
Chief Medical Officer |
RSU-Zuteilung |
250,000 |
- |
- |
250,000 |
| 2022-08-02 |
Smith Sean Michael |
Principal Accounting Officer |
RSU-Zuteilung |
150,000 |
- |
- |
150,000 |
| 2022-08-02 |
Cochener Donna |
General Counsel, SVP Legal |
RSU-Zuteilung |
100,000 |
- |
- |
100,000 |
| 2022-05-12 |
Simpson Todd E |
Director |
RSU-Zuteilung |
25,000 |
- |
- |
25,000 |
| 2022-05-12 |
Baker Bros. Advisors Lp |
Director |
RSU-Zuteilung |
25,000 |
$1.07 |
$26.75K |
25,000 |
| 2022-05-12 |
Palekar Rohan |
Director |
RSU-Zuteilung |
25,000 |
$1.07 |
$26.75K |
25,000 |
| 2022-05-12 |
Babler Martin |
Director |
RSU-Zuteilung |
25,000 |
$1.07 |
$26.75K |
25,000 |
| 2022-05-12 |
Baker Bros. Advisors (gp) Llc |
Director |
RSU-Zuteilung |
25,000 |
- |
- |
25,000 |
| 2022-05-12 |
Noonberg Sarah B. |
Director |
RSU-Zuteilung |
25,000 |
$1.07 |
$26.75K |
25,000 |
| 2022-05-12 |
Lavelle Erin |
Director |
RSU-Zuteilung |
25,000 |
- |
- |
25,000 |
| 2022-04-30 |
Patel Priti |
Chief Medical Officer |
Informierter Verkauf |
5,538 |
$1.22 |
$6.75K |
6,462 |
| 2022-03-14 |
Cochener Donna |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2022-03-14 |
Cochener Donna |
General Counsel, SVP Legal |
RSU-Zuteilung |
400,000 |
- |
- |
400,000 |
| 2022-03-02 |
Smith Sean Michael |
Principal Accounting Officer |
Veräußerung |
25,000 |
- |
- |
- |
| 2022-03-02 |
Smith Sean Michael |
Principal Accounting Officer |
RSU-Zuteilung |
80,000 |
- |
- |
80,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
